IRS-2 Antibodies

Santa Cruz Biotechnology offers a broad range of IRS-2 Antibodies for research focused on understanding the insulin signaling pathway. IRS-2 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). IRS-2, or Insulin Receptor Substrate 2, plays a critical role in mediating the effects of insulin and insulin-like growth factors, influencing cellular processes such as glucose metabolism, cell growth, and differentiation. The involvement of IRS-2 in metabolic disorders, including obesity and type 2 diabetes, makes it a significant target for therapeutic research. Researchers investigating IRS-2 can uncover crucial information about insulin signaling pathways and their relationship to various diseases. Understanding IRS-2 function and regulation provides valuable insights into metabolic disease mechanisms and potential therapeutic approaches. The molecular characterization of IRS-2 continues to reveal new aspects of insulin signaling and cellular regulation. Santa Cruz Biotechnology monoclonal antibodies for IRS-2 support researchers worldwide in advancing our understanding of metabolic diseases and potential treatments.